Longevity News

Early systemic immune-inflammation index is associated with mortality and functional outcome in brainstem hemorrhage

Source: Frontiers - Health • Published: 26 Aug 2026, 00:00

Early systemic immune-inflammation index is associated with mortality and functional outcome in brainstem hemorrhage

Early systemic immune-inflammation index trajectories in acute brainstem hemorrhage — a clinical research article preview offering prognostic biomarker insights and patient risk stratification.

Key Takeaways
  • Higher early SII values correlate with increased mortality risk in brainstem hemorrhage patients
  • Elevated SII during the acute phase associates with worse functional outcomes at follow-up
  • SII is presented as a low-cost, reproducible blood biomarker for inflammatory risk stratification after hemorrhage
Read Original Source

Continue exploring

Related longevity signals

Frontiers - HealthMultimodal integration of carotid plaque ultrasound radiomics and dynamic systemic immune-inflammation trajectories for subacute risk stratification after stroke thrombectomy: development and internal validation of an exploratory prognostic modelA study tests whether combining carotid ultrasound radiomics with week-long immune‑inflammation trajectories improves 90‑day outcome prediction after stroke thrombectomy.Frontiers - HealthResources are associated with functional outcome and brain morphometry in childhood cancer survivorsChildhood cancer survivors resources and their links to long-term cognitive, motor, and brain-structure outcomes — what this research article examines and why it matters.Frontiers - HealthThe association between metabolic dysfunction-associated fatty liver disease and left ventricular mass index in patients with schizophrenia with long-term hospitalizationReports an analysis linking metabolic dysfunction-associated fatty liver disease to higher left ventricular mass index in long-term hospitalized schizophrenia patients.Frontiers - HealthCancer-Associated Fibroblasts and Extracellular Matrix Remodeling Driving Drug Resistance and Immune Evasion in Bladder Cancer: Research ProgressA review synthesizing how cancer-associated fibroblasts reshape the extracellular matrix to drive drug resistance and immune evasion in bladder cancer.